ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
19.80
-0.15 (-0.75%)
May 8, 2026, 1:30 PM CST

ScinoPharm Taiwan Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
15,65713,24517,43620,87620,12419,492
Market Cap Growth
11.24%-24.04%-16.48%3.73%3.25%-14.56%
Enterprise Value
13,25311,17014,13617,53016,52716,275
Last Close Price
19.8016.7521.6025.6024.3723.17
PE Ratio
148.9296.7151.3872.7256.9880.06
Forward PE
-108.27108.27102.5252.6036.38
PS Ratio
4.994.195.126.556.177.06
PB Ratio
1.521.261.662.011.931.85
P/TBV Ratio
1.521.261.662.021.931.86
P/FCF Ratio
44.9343.4837.04-37.9399.76
P/OCF Ratio
25.3022.2323.2290.3226.0138.23
EV/Sales Ratio
4.233.534.155.505.065.89
EV/EBITDA Ratio
21.7418.4617.8523.0719.9324.83
EV/EBIT Ratio
141.59102.5744.0355.7440.7656.39
EV/FCF Ratio
38.0336.6730.03-31.1583.29
Debt / Equity Ratio
0.080.070.060.060.070.05
Debt / EBITDA Ratio
1.411.220.830.800.800.83
Debt / FCF Ratio
2.472.501.44-1.282.85
Net Debt / Equity Ratio
-0.23-0.22-0.33-0.32-0.35-0.33
Net Debt / EBITDA Ratio
-4.05-3.88-4.41-4.37-4.36-5.38
Net Debt / FCF Ratio
-6.90-7.71-7.4189.04-6.82-18.04
Asset Turnover
0.260.270.290.270.280.24
Inventory Turnover
1.141.251.321.461.591.14
Quick Ratio
4.345.266.286.526.168.04
Current Ratio
6.557.748.618.757.8710.73
Return on Equity (ROE)
1.02%1.30%3.25%2.76%3.37%2.31%
Return on Assets (ROA)
0.49%0.57%1.70%1.66%2.15%1.53%
Return on Invested Capital (ROIC)
1.15%1.33%3.75%3.73%4.73%3.31%
Return on Capital Employed (ROCE)
0.90%1.00%2.90%2.90%3.70%2.60%
Earnings Yield
0.69%1.03%1.95%1.38%1.75%1.25%
FCF Yield
2.23%2.30%2.70%-0.18%2.64%1.00%
Dividend Yield
1.46%1.73%1.62%1.17%1.48%2.07%
Payout Ratio
257.55%202.09%69.91%99.17%107.46%162.39%
Buyback Yield / Dilution
0.29%0.12%-0.07%0.04%-0.05%-0.01%
Total Shareholder Return
1.75%1.85%1.55%1.22%1.43%2.06%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.